menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Blood pressure medication recalled nationwide under FDA's Class II risk level

261 0
28.09.2026

Blood pressure medication recalled nationwide under FDA’s Class II risk level

descriptions off, selected

captions settings, opens captions settings dialog

captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

End of dialog window.

When should you be concerned about a recall?

When should you be concerned about a recall?

(NEXSTAR) – If you are one of millions of Americans taking medication to lower blood pressure, you may want to check the label.

Inventia Healthcare Limited, based in Mumbai, India, is voluntarily recalling 13,567 bottles of chlorthalidone tablets that may not dissolve properly, potentially lowering the dosage that gets absorbed by the body. The bottles of 25 mg tablets being recalled nationwide have the batch number RISA24002 and an expiration date of March 2027.

The chlorthalidone recall follows Inventia........

© The Hill